☆ 4.4 Article

SARS-CoV-2 B.1.1.7 lineage rapidly spreads and replaces R.1 lineage in Japan: Serial and stationary observation in a community

INFECTION GENETICS AND EVOLUTION (2021)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Infectious Diseases

A discernable increase in the severe acute respiratory syndrome coronavirus 2 R.1 lineage carrying an E484K spike protein mutation in Japan

Tsuyoshi Sekizuka et al.

Summary: Three waves of COVID-19 in Japan have been characterized by distinct PANGO lineages, with the E484K mutation in the spike protein of the R.1 lineage showing up to 40% predominance. It is essential to pay attention to potential variants to prevent the emergence of mutants, highlighting the importance of real-time genome surveillance in containing COVID-19 clusters.

INFECTION GENETICS AND EVOLUTION (2021)

添加到收藏夹

Article Microbiology

Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization

Zhuoming Liu et al.

Summary: The study found that antibodies targeting the SARS-CoV-2 spike protein have escape mutations, different monoclonal antibodies have unique resistance profiles, some mutants are resistant to multiple antibodies while some variants can escape neutralization by convalescent sera. Comparing antibody-mediated mutations with circulating SARS-CoV-2 sequences revealed substitutions that may weaken neutralizing immune responses in some individuals, warranting further investigation.

CELL HOST & MICROBE (2021)

添加到收藏夹

Article Medicine, General & Internal

Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012/1: matched cohort study

Robert Challen et al.

Summary: The study found that the mortality hazard ratio associated with infection with VOC-202012/1 compared with previously circulating variants was 1.64, indicating an increase in deaths from 2.5 to 4.1 per 1000 detected cases in comparatively low risk group of covid-19 patients in the community. This suggests that infection with VOC-202012/1 may lead to substantial additional mortality compared with previously circulating variants, impacting healthcare capacity planning and control policies.

BMJ-BRITISH MEDICAL JOURNAL (2021)

添加到收藏夹

Article Infectious Diseases

Novel SARS-CoV-2 variants: the pandemics within the pandemic

Erik Boehm et al.

Summary: Many new variants of SARS-CoV-2 have been identified as variants of concern/interest due to increased transmissibility, severity, immune escape, and reduced vaccine efficacy. These variants often share similar mutations, such as N501Y and E484K, which lead to partial immune escape, decreased vaccine efficacy, and potentially increased severity.

CLINICAL MICROBIOLOGY AND INFECTION (2021)

添加到收藏夹

Article Infectious Diseases

Prospective study of 1308 nasopharyngeal swabs from 1033 patients using the LUMIPULSE SARS-CoV-2 antigen test: Comparison with RT-qPCR

Yosuke Hirotsu et al.

Summary: This prospective study demonstrated that the LUMIPULSE antigen test is highly accurate for SARS-CoV-2 detection, showing high sensitivity and specificity, particularly in diagnosing the disease accurately in the late phase of infection.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)

添加到收藏夹

Letter Infectious Diseases

SARS-CoV-2 B.1.1.7 and B.1.351 spike variants bind human ACE2 with increased affinity

Muthukumar Ramanathan et al.

LANCET INFECTIOUS DISEASES (2021)

添加到收藏夹

Article Multidisciplinary Sciences

Assessing transmissibility of SARS-CoV-2 lineage B.1.1.7 in England

Erik Volz et al.

Summary: Genetic and testing data from England indicate that the SARS-CoV-2 variant B.1.1.7 has a transmission advantage over other lineages, showing a rapid expansion during autumn 2020. Analysis of S gene target failures (SGTF) in community-based diagnostic PCR testing suggests that B.1.1.7 is more transmissible than non-variant of concern lineages and has a significant transmission advantage, with a reproduction number 50% to 100% higher. Additionally, cases of B.1.1.7 appear to include a larger share of under 20-year-olds compared to non-variant cases.

NATURE (2021)

添加到收藏夹

Editorial Material Surgery

Postvaccination SARS-CoV-2 infections among skilled nursing facility residents and staff members - Chicago, Illinois, December 2020-March 2021

Richard A. Teran et al.

AMERICAN JOURNAL OF TRANSPLANTATION (2021)

添加到收藏夹

Article Infectious Diseases

Predicted dominance of variant Delta of SARS-CoV-2 before Tokyo Olympic Games, Japan, July 2021

Kimihito Ito et al.

Summary: Based on the numbers of SARS-CoV-2 variants detected in Japan as of June 13, 2021, the relative instantaneous reproduction numbers (R-RI) of the R.1, Alpha, and Delta variants were estimated. The R-RI values indicate that the Delta variant is expected to surpass the Alpha variant in frequency in Japan before July 23, 2021.

EUROSURVEILLANCE (2021)

添加到收藏夹

Letter Infectious Diseases

Discovery of a SARS-CoV-2 variant from the P.1 lineage harboring K417T/E484K/N501Y mutations in Kofu, Japan

Yosuke Hirotsu et al.

JOURNAL OF INFECTION (2021)

添加到收藏夹

Article Virology

SARS-CoV-2 R.1 lineage variants that prevailed in Tokyo in March 2021

Katsutoshi Nagano et al.

Summary: This study conducted PCR testing on patients who visited the hospital between February and April 2021, revealing a rapid increase in cases with N501Y and E484K mutations from 8% to 46%, with these mutations being associated with R.1 lineage variants. However, there was no evidence of increased disease severity related to the R.1 variants.

JOURNAL OF MEDICAL VIROLOGY (2021)

添加到收藏夹

Article Multidisciplinary Sciences

BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants

Jianying Liu et al.

Summary: Serum samples from individuals vaccinated with the BNT162b2 vaccine can neutralize various SARS-CoV-2 variants, indicating mass immunization as a central strategy to end the global COVID-19 pandemic.

NATURE (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2-mRNA-vaccinated individuals

Talia Kustin et al.

Summary: Breakthrough SARS-CoV-2 infections post-vaccination may be caused by B.1.1.7 or B.1.351 variants, indicating the importance of robust vaccination. Reduced vaccine effectiveness against these variants was observed in the study, highlighting the need for continued surveillance and enhanced vaccination efforts.

NATURE MEDICINE (2021)

添加到收藏夹

Article Virology

A Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving Epidemic

Andreas C. Chrysostomou et al.

Summary: The study identified 34 different lineages of SARS-CoV-2 in Cyprus, with certain lineages like B.1.258, B.1.1.29, B.1.177, B.1.2, B.1, and B.1.1.7 being the most prevalent during the study period. Phylodynamic analysis showed three consecutive surges with specific lineages dominating different time periods, while genetic analysis revealed mutations within the S protein conferring higher transmissibility and/or antibody escape capabilities to the virus. Phylogeographic analysis indicated that Cyprus receives lineages from multiple countries, contributing to the establishment of an ever-evolving and polyphyletic virus on the island.

VIRUSES-BASEL (2021)

添加到收藏夹

Article Microbiology

Detection of R.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with spike protein W152L/E484K/G769V mutations in Japan

Yosuke Hirotsu et al.

Summary: A study revealed the emergence of a novel coronavirus lineage with multiple mutations in Japan, including potential escape mutations in the spike protein. This lineage has been spreading in Japan since early 2021 and requires ongoing monitoring for global implications.

PLOS PATHOGENS (2021)

添加到收藏夹

Article Medicine, Research & Experimental

Dominance of Alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City

Ralf Duerr et al.

Summary: The study found that breakthrough infections still occur after receiving COVID-19 mRNA vaccines, but the vaccines have high efficacy against B.1.1.7 and B.1.526 variants.

JOURNAL OF CLINICAL INVESTIGATION (2021)

添加到收藏夹

Article Immunology

Robust Antibody Responses to the BNT162b2 mRNA Vaccine Occur Within a Week After the First Dose in Previously Infected Individuals and After the Second Dose in Uninfected Individuals

Yosuke Hirotsu et al.

Summary: A study on healthcare workers vaccinated with the BNT162b2 mRNA vaccine found that antibody responses were significantly enhanced after the second dose in infection-naive individuals and after the first dose in previously infected individuals. The robust boosting effect of immunization suggests that increased antibody titres following exposure to the virus may limit viral replication, prolong the incubation period, or reduce the severity of the disease.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Infectious Diseases

Comparison of automated SARS-CoV-2 antigen test for COVID-19 infection with quantitative RT-PCR using 313 nasopharyngeal swabs, including from seven serially followed patients

Yosuke Hirotsu et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

添加到收藏夹

Article Microbiology

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Andrew Rambaut et al.

NATURE MICROBIOLOGY (2020)

添加到收藏夹

Article Biochemistry & Molecular Biology

Structural and Functional Analysis of the D614G SARS-CoV-2 Spike Protein Variant

Leonid Yurkovetskiy et al.

CELL (2020)

添加到收藏夹

Article Biochemical Research Methods

Double-quencher probes improve detection sensitivity toward Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a reverse-transcription polymerase chain reaction (RT-PCR) assay

Yosuke Hirotsu et al.

JOURNAL OF VIROLOGICAL METHODS (2020)

添加到收藏夹

Article Multidisciplinary Sciences

Pooling RT-qPCR testing for SARS-CoV-2 in 1000 individuals of healthy and infection-suspected patients

Yosuke Hirotsu et al.

SCIENTIFIC REPORTS (2020)

添加到收藏夹

Article Biochemical Research Methods

Nextstrain: real-time tracking of pathogen evolution

James Hadfield et al.

BIOINFORMATICS (2018)

添加到收藏夹

Editorial Material Infectious Diseases

GISAID: Global initiative on sharing all influenza data - from vision to reality

Yuelong Shu et al.

EUROSURVEILLANCE (2017)

添加到收藏夹

Article Biotechnology & Applied Microbiology

Viral deep sequencing needs an adaptive approach: IRMA, the iterative refinement meta-assembler

Samuel S. Shepard et al.

BMC GENOMICS (2016)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.